Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2010
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759604A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758610A1 Process 738
10/28/2010CA2758505A1 Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity
10/28/2010CA2758210A1 Proline derivatives as cathepsin inhibitors
10/28/2010CA2752826A1 Preparation of c-pyrazine-methylamines
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243777A1 Method for manufacturing Pyridyl-substituted pyrazoles
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243539A2 Functionalized ionic liquids, and methods of use thereof
10/27/2010EP2242749A1 Novel pyridinones and pyridazinones
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/27/2010EP2099761B1 Antibacterial quinoline derivatives
10/27/2010EP2091938B1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1742634B1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1871005B 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/27/2010CN1812982B Benzodiazepine CGRP receptor antagonists
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN101874020A Piperidine derivatives as agonists of muscarinic receptors
10/27/2010CN101870692A Novel piperazinyl pyridazine compounds
10/27/2010CN101870691A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/26/2010USRE41898 halide salt of a 1-(hydroxyiminomethyl-1-pyridino)-3-(halomethyl)-2-oxapropane is prepared by adding a pyridinealdoxime to a bis-halomethylether at 30-100 degrees C. in such a manner that the bis-halomethylether is maintained in excess throughout the addition
10/26/2010US7820827 3,4-disubstituted-4-aryl-piperidine; treating pain with opioids while avoiding side effects such as constipation, nausea and vomiting by administering said compounds; treating gastrointestinal disorders such as ileus (bowel obstruction)
10/26/2010US7820826 for modulating nicotinic acetylcholine receptors;
10/26/2010US7820821 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820815 Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines
10/26/2010US7820699 5-Chloro-thiophene-2-carboxylic acid ((3S ,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide; anticoagulant, inhibit coagulation factor Xa
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820696 Compounds and methods for controlling fungi, bacteria and insects
10/26/2010US7820693 2-Oxo-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-yl]oxazolidin-5-ylmethyl(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)acetate; 7-(2-Oxoazetidin-1-yl)-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one; anticarcinogenic agent ( solid cancer)
10/26/2010US7820682 3-{[(3R)-1-(3,5-dimethoxy-4-methylbenzoyl)-5-(2-phenylethyl)-3-pyrrolidinyl]oxy}benzoic acid methyl ester; treatment of urinary system disease; anticarcinogenic agent, antiarthritic agent, treats proliferative disease, inflammation/immune system disease, Sjogren*s syndrome, brain-related disease
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820677 for treatment of serotonin-related disorder, particularly 5-HT2C receptor related ( type II diabetes and obesity)
10/26/2010US7820672 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
10/26/2010US7820669 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
10/26/2010US7820663 such as alpha -[(3-azabicyclo[3.3.0]octyl-3-amino)methylene]-N-(4-chlorophenyl)-3-methyl-5-isoxazoleacetamide, allosteric modulators of alpha 7 nicotinic acetylcholine receptor; central nervous system disorders, sleep disorders, neurodegenerative disorders
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820647 e.g. 1-[4-chloro-6-(2,2,2-trifluoro-1-methylethylamino)-5-(2,4,6-trifluorophenyl)pyrimidin-2-yl]-pyrrolidin-2-one; controlling phytopathogenic harmful fungi, such as Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes; materials, plants, soil, seeds;
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010US7820453 Reacting astemizole with potassium channel moderators; complexing; calibration; kits
10/26/2010US7820144 Receptor selective cannabimimetic aminoalkylindoles
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2422708C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2353627C Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010120750A2 Amorphous esomeprazole magnesium
10/21/2010WO2010119881A1 Indoline compound
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119078A1 Indole derivative modulators of the alpha 7 nachr
10/21/2010WO2010119050A1 New rac1 inhibitors as potential pharmacological agents for heart failure treatment
10/21/2010WO2010118575A1 Racemic enantiomers resoluting
10/21/2010WO2010099054A3 Soluble guanylate cyclase activators
10/21/2010WO2010089327A3 Indole derivatives as anticancer agents
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100267959 Process for the preparation of esomeprazole magnesium dihydrate
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267776 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/21/2010US20100267769 Substituted Bicyclocarboxyamide Compounds
10/21/2010US20100267755 Pyrimidine derivatives
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267743 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267724 S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267687 Phenylpyrazole derivatives
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 1080